The Latest Cardiac and Vascular News
REDWOOD CITY, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the appointment of Wayne J. Riley, MD, to its Board of Directors. “We are very honored to have Dr. Riley join HeartFlow’s Board of Directors,” said William C. Weldon, Chairman of […]
— Patency and host cell remodeling of the HAV were observed in all study implants – — Preclinical study is one component of Humacyte’s expansion of the testing of the HAV in a broader cardiac bypass surgery application – DURHAM, N.C., Nov. 16, 2021 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a […]
Multinational study data highlighted at 2021 American Heart Association (AHA) Scientific Sessions November 16, 2021 09:00 AM Eastern Standard Time KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc. today announces the presentation of multinational patient data demonstrating its HART CADhs blood test is significantly more accurate than high sensitivity troponin in determining whether a diabetic patient has […]
Debuted as a public company and strengthened liquidity position with $95.1 million in gross proceeds from the business combination with Chardan Healthcare Acquisition 2 Corp and concurrent PIPE financing Released topline preclinical data demonstrating feasibility of REN-001 to transduce a large animal heart via local infusion at low vector doses […]
MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today reported financial results for the third quarter of 2021 and provided a business update. “As we approach the new year, […]
Conference call begins at 4:30 p.m. Eastern time today November 15, 2021 04:05 PM Eastern Standard Time CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three and nine months […]
– As the world’s first ring-type medical device to monitor heart signals, CART-I continually measures atrial fibrillation 24/7 – In-house developed AI technology is used to provide significant medical data to patients and medical professionals, leading to an increased atrial fibrillation diagnosis rate – Discount promotion is planned in Britain […]
– Etripamil significantly decreased heart rate during SVT episodes and independent of conversion to SR – – HR changes occurred within 5 minutes and were sustained for 60 minutes – – Data presented at AHA Scientific Sessions 2021 – MONTREAL and CHARLOTTE, N.C., Nov. 15, 2021 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical […]
– Abbott included on DJSI for 17 consecutive years for strong environmental, social and governance (ESG) performance – Top score in the Health Care Equipment & Supplies sector reflects Abbott’s 2030 Sustainability Plan focus on innovating for greater access to life-changing technologies and breaking down barriers to health equity ABBOTT […]
The implant took place at the University Medical Centre Utrecht, The Netherlands November 15, 2021 01:00 AM Eastern Standard Time PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic […]
